Pro Medicus Limited ( (AU:PME) ) just unveiled an announcement.
Pro Medicus Limited has announced the cessation of 2,610 ordinary fully paid securities through an on-market buy-back, effective April 4, 2025. This move is part of the company’s capital management strategy and may impact its share structure, potentially enhancing shareholder value and optimizing its financial operations.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare industry, specializing in the development and provision of medical imaging software and services. The company focuses on delivering innovative solutions to improve the efficiency and quality of radiology services in the healthcare sector.
YTD Price Performance: -32.31%
Average Trading Volume: 472
Technical Sentiment Signal: Sell
Current Market Cap: $11.98B
See more data about PME stock on TipRanks’ Stock Analysis page.